14 results
424B5
QLGN
Qualigen Therapeutics Inc
1 Dec 21
Prospectus supplement for primary offering
2:28pm
that may interfere with its operations. Extreme weather events and other natural disasters could severely disrupt its operations, and have a material adverse
10-KT
QLGN
Qualigen Therapeutics Inc
31 Mar 21
Annual report (with FYE transition)
4:33pm
interfere with our operations. Extreme weather events and other natural disasters could severely disrupt our operations, and have a material adverse effect
424B5
beutw3jna8nc4mapr
18 Dec 20
Prospectus supplement for primary offering
1:26pm
424B5
hhyvjdk
2 Oct 20
Prospectus supplement for primary offering
4:24pm
424B5
wmcc0knmsdz2
4 Aug 20
Prospectus supplement for primary offering
6:16am
424B5
imjj5g pnshmk
10 Jul 20
Prospectus supplement for primary offering
2:35pm
424B3
gtn0px4fs
9 Apr 20
Prospectus supplement
9:30am
S-4/A
6mdpf
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4
ca4wdotmxv5l0k7
4 Feb 20
Registration of securities issued in business combination transactions
6:26am
- Prev
- 1
- Next